Skip to main content
. 2021 Aug 13;9:699304. doi: 10.3389/fcell.2021.699304

FIGURE 2.

FIGURE 2

The regulations of iron metabolism and redox homeostasis in cancer cells. Cancer cells display higher iron transporting, storage, and bioavailability as well as increased levels of glutathione (GSH) and GPX4 for detoxification in contrast to normal cells. Iron regulatory proteins (IRP1/2) play a central role in maintaining an adequate iron homeostasis in cancer cells by regulating the stability of each mRNA differentially [increasing for transferrin receptor 1 (TFRC) and SLC11A2, while decreasing for light chain (FTL)/H protecting cells]. The classical marker of hypoxia, HIF-1α, also supports the stabilization of TFRC, IRP1/2, as well as FTL/H to promote both iron absorption and availability in cancer cells.